Recent blog posts
Spasmodic dysphonia Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
Latest Hotspot
10 min read
Spasmodic dysphonia Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
Explore the 2026 Spasmodic dysphonia indication strategy: epidemiology, unmet need, target biology, clinical competition and deal signals using PatSnap MCP evidence.
Read →
Vocal fold scarring Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
Latest Hotspot
10 min read
Vocal fold scarring Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
Explore the 2026 Vocal fold scarring indication strategy: epidemiology, unmet need, target biology, clinical competition and deal signals using PatSnap MCP evidence.
Read →
Hyperacusis Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
Latest Hotspot
10 min read
Hyperacusis Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
Explore the 2026 Hyperacusis indication strategy: epidemiology, unmet need, target biology, clinical competition and deal signals using PatSnap MCP evidence.
Read →
Pulsatile tinnitus Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
Latest Hotspot
10 min read
Pulsatile tinnitus Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
Explore the 2026 Pulsatile tinnitus indication strategy: epidemiology, unmet need, target biology, clinical competition and deal signals using PatSnap MCP evidence.
Read →
Cochlear synaptopathy Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
Latest Hotspot
10 min read
Cochlear synaptopathy Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Cochlear synaptopathy strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Read →
GJB2-related hearing loss Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
Latest Hotspot
10 min read
GJB2-related hearing loss Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 GJB2-related hearing loss strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Read →
Auditory neuropathy spectrum disorder Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
Latest Hotspot
10 min read
Auditory neuropathy spectrum disorder Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Auditory neuropathy spectrum disorder strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap.
Read →
Noise-induced hearing loss Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
Latest Hotspot
10 min read
Noise-induced hearing loss Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Noise-induced hearing loss strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Read →
Age-related hearing loss Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
Latest Hotspot
10 min read
Age-related hearing loss Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Age-related hearing loss strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Read →
Usher syndrome type 2 Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
Latest Hotspot
10 min read
Usher syndrome type 2 Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Usher syndrome type 2 strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Read →
Usher syndrome type 1 Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
Latest Hotspot
10 min read
Usher syndrome type 1 Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Usher syndrome type 1 strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Read →
Pendred syndrome Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
Latest Hotspot
10 min read
Pendred syndrome Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
Explore the 2026 Pendred syndrome indication strategy: epidemiology, unmet need, target biology, clinical competition and deal signals using PatSnap MCP evidence.
Read →